alltrials
AllTrials puts FDA under pressure with Trials Tracker
February 22, 2018Medical Communications alltrials, biotech, drugs, pharma, pharmaceutical
A year to the day that the FDA unveiled its Final Rule, which sees organisation given 13 months from clinical …
Judge rules pharma has ‘ethical’ transparency obligation – reaction
July 29, 2015Research and Development Ben Goldacre, Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, sense about science, transparency
Both sides of a bitterly contested legal battle over a major part of the industry’s transparency drive have reacted to …
Judge backs HRA in transparency legal case
July 28, 2015Research and Development EU Clinical Trial Regulation, Richmond Pharmacology, alltrials, clinical trial regulation, clinical trials, health research authority, sense about science, transparency
A judge has ruled that there are likely to be no legal grounds to block the Health Research Authority’s plans …
Ruling in transparency case ‘due within days’
July 17, 2015Research and Development EMIG, EU Clinical Trial Regulation, Ethical Medicines Industry Group, Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, sense about science, transparency
A judge is set to rule on a controversial legal challenge to the requirement for the pharma industry to register …
It’s time the industry spoke out about legal challenge to clinical trial transparency
July 16, 2015Research and Development Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, judicial review, legal challenge, sense about science, transparency
The judicial review brought by Richmond Pharmacology against the Health Research Authority – erroneous, a waste of public money and …
Industry awaits outcome of transparency legal challenge
July 16, 2015Research and Development Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, judicial review, legal challenge, sense about science, transparency
A judge will today hear arguments from the Health Research Authority and campaigners who are contesting a judicial review of …
World Health Organisation calls for full trial transparency
April 14, 2015Research and Development, Sales and Marketing Ben Goldacre, EU, WHO, World Health Organisation, alltrials, clinical trials, sense about science, transparency
The World Health Organization has thrown its weight behind clinical trial transparency in a new statement on its position. WHO …
Government spending on Tamfilu is justified
January 30, 2015Research and Development, Sales and Marketing BMJ, Lancet, Roche, Tamiflu, alltrials, oseltamivir, transparency
The most thorough analysis of Roche’s Tamiflu to date suggests that the controversial treatment can shorten the duration of flu …
EMA launches consultation on clinical trials
January 22, 2015Research and Development, Sales and Marketing EFPIA, EMA, EU, Europe, Goldacre, alltrials, transparency
The European Medicines Agency has invited pharma to comment on its proposals to ramp up transparency in the industry and …
Pharma and transparency: actions speak louder than words
October 13, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, UK, alltrials, andrew powrie-smith, hcp, transparency
As an industry we continue to deliver innovative, life changing medicines and rewrite the story of many diseases, yet our …
Mixed response to EMA data transparency plans
October 3, 2014Medical Communications, Research and Development, Sales and Marketing AbbVie, BMJ, Ben Goldacre, EMA, alltrials, transparency
The European Medicines Agency has passed new rules that will mandate pharma to release more of its clinical trial data …
NICE seeks more trial data from pharma
September 10, 2014Medical Communications, Research and Development, Sales and Marketing David Haslam, NICE, Tamiflu, alltrials, transparency
NICE is calling on pharma to release more data so it can better assess the costs of new medicines.The watchdog …
Janssen: why transparency is essential to the health of our industry
August 29, 2014Medical Communications, Research and Development, Sales and Marketing EFPIA, EMEA, Goldacre, Janssen, alltrials, transparency
The pharmaceutical industry is moving forward, working together to ensure patients have access to new and innovative medicines.However, more must …
EMA delays trial transparency – again
July 10, 2014Medical Communications, Research and Development, Sales and Marketing EMA, Goldacre, Rasi, alltrials, clinical trials, transparency
The European Medicines Agency has once again said that it is to delay the launch of its new clinical trial …
EMA changes ‘on screen’ data policy
June 16, 2014Medical Communications, Research and Development, Sales and Marketing AbbVie, EMA, Goldacre, Humira, alltrials, transparency
The European Medicines Agency is to formally agree its policy on the vexed issue of the publication of clinical trial …
Latest content
